[225Ac]Ac- and [111In]In-DOTA-trastuzumab theranostic pair: cellular dosimetry and cytotoxicity in vitro and tumour and normal tissue uptake in vivo in NRG mice with HER2-positive human breast cancer xenografts

[225Ac]Ac- and [111In]In-DOTA-trastuzumab theranostic pair: cellular dosimetry and cytotoxicity in vitro and tumour and normal tissue uptake in vivo in NRG mice with HER2-positive human breast cancer xenografts

Abstract Background Trastuzumab (Herceptin) has improved the outcome for patients with HER2-positive breast cancer (BC) but brain metastases (BM) remain a challenge due to poor uptake of trastuzumab into the brain. Radioimmunotherapy (RIT) with trastuzumab labeled with α-particle emitting, 225Ac may...

Full description

Bibliographic Details
Main Authors: Misaki Kondo, Zhongli Cai, Conrad Chan, Nubaira Forkan, Raymond M. Reilly
Format: Article
Language:English
Published: SpringerOpen 2023-09-01
Series:EJNMMI Radiopharmacy and Chemistry
Subjects:
Trastuzumab
225Ac
α-particles
HER2
Breast cancer
111In
Online Access:https://doi.org/10.1186/s41181-023-00208-0

Internet

https://doi.org/10.1186/s41181-023-00208-0

Similar Items